Announcements Trials

Browse Landscape

Phase

Phase 3 1 Phase 2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 8 Uterine Cervical Neoplasms 2 Lymphoma, Large B-Cell, Diffuse 2 Carcinoma, Non-Small-Cell Lung 2 Breast Neoplasms 2 Vulvar Neoplasms 1 Vaginal Neoplasms 1 Urinary Bladder Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Solitary Fibrous Tumor, Pleural 1 Rectal Neoplasms 1 Neuroblastoma 1 Muscle-invasive Bladder Cancer 1 Mouth Neoplasms 1 Mesothelioma, Malignant 1 Melanoma 1 Lung Neoplasms 1 Leukemia, Myeloid, Acute 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Head and Neck Neoplasms 1 Esophageal Squamous Cell Carcinoma 1 Esophageal Neoplasms 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Carcinoma, Squamous Cell 1 Carcinoma, Renal Cell 1 Brain Neoplasms 1 Body Weight Changes 1 Anorexia 1 Adenocarcinoma, Bronchiolo-Alveolar 1

Interventions

Temozolomide 73 Bevacizumab 57 Radiotherapy 40 Radiosurgery 28 Carboplatin 23 Nivolumab 17 Etoposide 17 Cisplatin 17 pembrolizumab 16 Irinotecan 16 Ipilimumab 15 Magnetic Resonance Spectroscopy 14 Erlotinib Hydrochloride 14 Cyclophosphamide 14 Carmustine 14 Pemetrexed 13 Topotecan 10 Surgical Procedures, Operative 10 Capecitabine 10 Lapatinib 9 Filgrastim 9 Trastuzumab 8 Thalidomide 8 Sunitinib 8 Paclitaxel 8 Lomustine 8 Aminolevulinic Acid 8 encorafenib 7 binimetinib 7 Vincristine 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Brain Neoplasms × Watchful Waiting × Clear all

NCT06974370 2026-05-26

ACTION-Brain

University of Vermont Medical Center

Phase 2 Recruiting

Brain Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡